![Lotte Sønderbjerg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lotte Sønderbjerg
Chief Administrative Officer at ASCENDIS PHARMA A/S
Net worth: 257 240 $ as of 2024-08-30
Profile
Currently, Lotte Sønderbjerg holds the position of Chief Administrative Officer & Senior VP at Ascendis Pharma An and Managing Director at Ascendis Pharma GmbH (a subsidiary of Ascendis Pharma A). In the past she was Senior Director-Human Resources & Finance at ACADIA Pharmaceuticals, Inc. and Senior Director-Finance & Human Resources at ACADIA Pharmaceuticals A (a subsidiary of ACADIA Pharmaceuticals, Inc.), Secretary for Novo Nordisk A, Senior Director-Finance & Human Resources at Veloxis Pharmaceuticals An and Personal Assistant at PricewaterhouseCoopers (Denmark). She received a graduate degree from the University of Aarhus.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ASCENDIS PHARMA A/S
0.00% | 2023-12-30 | 1,858 ( 0.00% ) | 257 240 $ | 2024-08-30 |
Lotte Sønderbjerg active positions
| Companies | Position | Start |
|---|---|---|
| ASCENDIS PHARMA A/S | Chief Administrative Officer | 2007-11-30 |
Ascendis Pharma GmbH
 Ascendis Pharma GmbH Pharmaceuticals: MajorHealth Technology Ascendis Pharma GmbH engages in research and development related to the administration of bioactive substances by cleavable linkers, as well as related activities. The company is headquartered in Heidelberg, Germany. | Chief Executive Officer | - |
Former positions of Lotte Sønderbjerg
| Companies | Position | End |
|---|---|---|
| VELOXIS PHARMACEUTICALS A/S | Director of Finance/CFO | 2006-12-31 |
ACADIA Pharmaceuticals A/S
 ACADIA Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Part of ACADIA Pharmaceuticals, Inc., ACADIA Pharmaceuticals A/S utilizes technology to fuel drug discovery and clinical development. The company is based in Glostrup, Denmark. The Danish company was founded by Peter Høngaard Andersen. | Director of Finance/CFO | - |
| ACADIA PHARMACEUTICALS INC. | Director of Finance/CFO | 2002-12-31 |
PricewaterhouseCoopers (Denmark)
 PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Secretary | - |
Training of Lotte Sønderbjerg
| University of Aarhus | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ASCENDIS PHARMA A/S | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| Private companies | 4 |
|---|---|
ACADIA Pharmaceuticals A/S
ACADIA Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Part of ACADIA Pharmaceuticals, Inc., ACADIA Pharmaceuticals A/S utilizes technology to fuel drug discovery and clinical development. The company is based in Glostrup, Denmark. The Danish company was founded by Peter Høngaard Andersen. | Commercial Services |
PricewaterhouseCoopers (Denmark)
PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Commercial Services |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Ascendis Pharma GmbH
Ascendis Pharma GmbH Pharmaceuticals: MajorHealth Technology Ascendis Pharma GmbH engages in research and development related to the administration of bioactive substances by cleavable linkers, as well as related activities. The company is headquartered in Heidelberg, Germany. | Health Technology |
- Stock Market
- Insiders
- Lotte Sønderbjerg
